Tools for Practice Outils pour la pratique


#327 To Treat or Not Treat Uncomplicated UTIs


CLINICAL QUESTION
QUESTION CLINIQUE
Do we need to use antibiotics to treat uncomplicated symptomatic urinary tract infections (UTI)?


BOTTOM LINE
RÉSULTAT FINAL
About two-thirds of non-pregnant adult women with uncomplicated symptomatic UTI will have persistent symptoms without treatment. At 3-4 days, 46% of women treated symptomatically with NSAIDs alone will be symptom-free versus 67% given antibiotics. By one month, fever and/or pyelonephritis developed in 1.2% given NSAIDs alone versus 0.2% given antibiotics. Women with uncomplicated symptomatic UTI should be offered antibiotics.



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
  • Results statistically significant unless indicated.
  • Systematic review (3 Randomized Controlled Trials [RCT], 346 non-pregnant women) focusing on patients given placebo.1
    • Symptom-free at 4-7 days: Approximately 31% without antibiotics (range 28%-60%) (PEER pooled data for average).
    • Symptom-free at 6 weeks: 36% without antibiotics.
    • Adverse events: No consistent difference. 2 untreated patients progressed to pyelonephritis (versus 1 treated with antibiotics).
  • Systematic review (4 RCTs, 1165 non-pregnant women) randomized to symptomatic treatment with NSAIDs (ibuprofen or diclofenac) versus antibiotics (ciprofloxacin, fosfomycin, norfloxacin, or pivmecillinam).2
    • Symptom-free at 3-4 days: NSAIDs lower (46%) versus antibiotics (67%), number needed to harm (NNH)=5 for using NSAIDs versus antibiotics.2
    • Adverse events (fever or pyelonephritis at ≤1 month): NSAID higher (1.2%) than antibiotics (0.2%), NNH=100 for using NSAIDs versus antibiotics.2
    • Other systematic review found similar.3
Context
  • Uncomplicated UTI is generally defined as adult (age 18-65) non-pregnant women with symptoms of cystitis with normal urinary tracts and immune systems.3,4
    • Asymptomatic bacteriuria is different and will be covered in future Tools for Practice.
  • Women presenting to primary care concerned about uncomplicated UTI have a high prevalence (>60%) of UTI; history and dipstick testing are generally of limited value.5
  • Empiric antibiotics maybe reasonable for uncomplicated UTI.
    • RCT, 309 non-pregnant women presenting to primary care with uncomplicated UTI were randomized to one of five antibiotic treatment options: Immediate, if dipstick positive, ≥2 symptoms, delayed for persistent symptoms, or if culture positive. All approaches provided similar symptom control.6
    • RCT of 59 non-pregnant women with uncomplicated UTI symptoms and negative dipstick urinalysis randomized to antibiotics or placebo found less dysuria after day 3 on antibiotics (24%) versus placebo (74%).7


Peter Wells November 14, 2022

Nice to confirm current practice

Peter Wells November 14, 2022

Confirms current practice

Bilkis Humama November 14, 2022

Confirm current practice

Donna Mahoney November 15, 2022

Will continue as is, then! Thanks!

sadia tahir November 16, 2022

confirm current practice

Andrew Affleck November 18, 2022

Confirms present practice

Andrew Affleck November 18, 2022

Makes sense

peter entwistle November 19, 2022

mmm – interesting way of presenting findings.
there are immediate patient harms and societal harms of using antibiotics for uncomplicated uti – surely a patient centred conversation 1in 5 chance they help and 1 100 chance will prevent some bad infection but antibiotics roughly have 1in 8 chance of causing harms


Latest Tools for Practice
Derniers outils pour la pratique

#379 Bumpin’ Up the Protection? RSV Vaccine in Pregnancy

How effective and safe is the respiratory syncytial virus (RSV) vaccine (AbrysvoTM) when given during pregnancy?
Read Lire 0.25 credits available Crédits disponibles

#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?

What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
Read Lire 0.25 credits available Crédits disponibles

#377 How to slow the flow IV: Combined oral contraceptives

In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • G. Michael Allan MD CCFP
  • Betsy Thomas BSc. Pharm
  • Jennifer Young MD CCFP-EM

1. Hoffmann T, Peiris R, Mar CD, et al. Br J Gen Pract. 2020; 70(699):e714-e22.

2. Ong Lopez AMC, Tan CJL, Yabon AS 2nd, et al. BMC Infect Dis. 2021; 21(1):619.

3. Carey MR, Vaughn VM, Mann J, et al. J Gen Intern Med. 2020; 35(6):1821-9.

4. Bent S, Nallamothu BK, Simel DL, et al. JAMA. 2002; 287(20):2701-10.

5. Young J, Thomas B, Allan GM. Tools for Practice, College of Family Physicians of Canada, 2022 October 3. #324. https://gomainpro.ca/wp-content/uploads/tools-for-practice/1664574685_tfp324_dxuti.pdf [Accessed October 28, 2022]

6. Little P, Moore MV, Turner S, et al. BMJ. 2010 Feb 5; 340:c199. doi: 10.1136/bmj.c199.

7. Richards D, Toop L, Chamber S, et al. BMJ, doi:10.1136/bmj.38496.452581.8F (published 22 June 2005)

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.